O-Antigen Targeted Vaccines Against Escherichia coli May Be Useful in Reducing Morbidity, Mortality, and Antimicrobial Resistance

Guilhem Royer^{1

2

3}, Olivier Clermont¹, Bénédicte Condamine¹, Mélanie Mercier-Darty^{2

3}, Cédric Laouénan^{1

4}, Agnès Lefort^{1

5}, Erick Denamur^{1

6}, Victoire de Lastours^{1

5}; COLIBAFI and SEPTICOLI Groups

Collaborators, Affiliations

Collaborators

COLIBAFI and SEPTICOLI Groups:
Michel Wolff, Loubna Alavoine, Xavier Duval, David Skurnik, Paul-Louis Woerther, Antoine Andremont, Etienne Carbonnelle, Olivier Lortholary, Xavier Nassif, Sophie Abgrall, Françoise Jaureguy, Bertrand Picard, Véronique Houdouin, Yannick Aujard, Stéphane Bonacorsi, Agnès Meybeck, Guilène Barnaud, Catherine Branger, Agnès Lefort, Bruno Fantin, Claire Bellier, Frédéric Bert, Marie-Hélène Nicolas-Chanoine, Bernard Page, Julie Cremniter, Jean-Louis Gaillard, Françoise Leturdu, Jean-Pierre Sollet, Gaëtan Plantefève, Xavière Panhard, France Mentré, Estelle Marcault, Florence Tubach, Virginie Zarrouk, Frederic Bert, Marion Duprilot, Véronique Leflon-Guibout, Naouale Maataoui, Laurence Armand, Liem Luong Nguyen, Rocco Collarino, Anne-Lise Munier, Hervé Jacquier, Emmanuel Lecorché, Laetitia Coutte, Camille Gomart, Ousser Ahmed Fateh, Luce Landraud, Jonathan Messika, Elisabeth Aslangul, Magdalena Gerin, Alexandre Bleibtreu, Mathilde Lescat, Violaine Walewski, Frederic Mechaï, Marion Dollat, Anne-Claire Maherault, Michel Wolff, Mélanie Mercier-Darty, Bernadette Basse

Affiliations

¹ Université de Paris, Infection Antimicrobials, Modelling and Evolution (IAME), unité mixte de recherche (UMR)1137, Institut National national de la santé et de la recherche médicale (INSERM), Paris, France.
² LABGeM, Génomique Métabolique, Genoscope, Institut François Jacob, centre de l'énergie atomique (CEA), Centre nationale de la recherche scientifique (CNRS), Université Paris-Saclay, Evry, France.
³ Service de Microbiologie, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Créteil, France.
⁴ Department d'Epidémiologie, Biostatistiques et Recherche Clinique, Hôpital Bichat, AP-HP, Paris, France.
⁵ Service de Médecine Interne, Hôpital Beaujon, AP-HP, Clichy, France.
⁶ Laboratoire de Génétique Moléculaire, Hôpital Bichat, AP-HP, Paris, France.

PMID: 34000003
DOI: 10.1093/cid/ciab458

Comment

O-Antigen Targeted Vaccines Against Escherichia coli May Be Useful in Reducing Morbidity, Mortality, and Antimicrobial Resistance

Guilhem Royer et al. Clin Infect Dis. 2022.

. 2022 Jan 29;74(2):364-366.

doi: 10.1093/cid/ciab458.

Authors

Collaborators

COLIBAFI and SEPTICOLI Groups:
Michel Wolff, Loubna Alavoine, Xavier Duval, David Skurnik, Paul-Louis Woerther, Antoine Andremont, Etienne Carbonnelle, Olivier Lortholary, Xavier Nassif, Sophie Abgrall, Françoise Jaureguy, Bertrand Picard, Véronique Houdouin, Yannick Aujard, Stéphane Bonacorsi, Agnès Meybeck, Guilène Barnaud, Catherine Branger, Agnès Lefort, Bruno Fantin, Claire Bellier, Frédéric Bert, Marie-Hélène Nicolas-Chanoine, Bernard Page, Julie Cremniter, Jean-Louis Gaillard, Françoise Leturdu, Jean-Pierre Sollet, Gaëtan Plantefève, Xavière Panhard, France Mentré, Estelle Marcault, Florence Tubach, Virginie Zarrouk, Frederic Bert, Marion Duprilot, Véronique Leflon-Guibout, Naouale Maataoui, Laurence Armand, Liem Luong Nguyen, Rocco Collarino, Anne-Lise Munier, Hervé Jacquier, Emmanuel Lecorché, Laetitia Coutte, Camille Gomart, Ousser Ahmed Fateh, Luce Landraud, Jonathan Messika, Elisabeth Aslangul, Magdalena Gerin, Alexandre Bleibtreu, Mathilde Lescat, Violaine Walewski, Frederic Mechaï, Marion Dollat, Anne-Claire Maherault, Michel Wolff, Mélanie Mercier-Darty, Bernadette Basse

Affiliations

¹ Université de Paris, Infection Antimicrobials, Modelling and Evolution (IAME), unité mixte de recherche (UMR)1137, Institut National national de la santé et de la recherche médicale (INSERM), Paris, France.
² LABGeM, Génomique Métabolique, Genoscope, Institut François Jacob, centre de l'énergie atomique (CEA), Centre nationale de la recherche scientifique (CNRS), Université Paris-Saclay, Evry, France.
³ Service de Microbiologie, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Créteil, France.
⁴ Department d'Epidémiologie, Biostatistiques et Recherche Clinique, Hôpital Bichat, AP-HP, Paris, France.
⁵ Service de Médecine Interne, Hôpital Beaujon, AP-HP, Clichy, France.
⁶ Laboratoire de Génétique Moléculaire, Hôpital Bichat, AP-HP, Paris, France.

PMID: 34000003
DOI: 10.1093/cid/ciab458

No abstract available

PubMed Disclaimer

Comment on

Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive Infections.
Lipworth S, Vihta KD, Chau KK, Kavanagh J, Davies T, George S, Barker L, Vaughan A, Andersson M, Jeffery K, Oakley S, Morgan M, Peto TEA, Crook DW, Walker AS, Stoesser N. Lipworth S, et al. Clin Infect Dis. 2021 Dec 16;73(12):2276-2282. doi: 10.1093/cid/ciab006. Clin Infect Dis. 2021. PMID: 33411882 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

O-Antigen Targeted Vaccines Against Escherichia coli May Be Useful in Reducing Morbidity, Mortality, and Antimicrobial Resistance

Collaborators

Affiliations

O-Antigen Targeted Vaccines Against Escherichia coli May Be Useful in Reducing Morbidity, Mortality, and Antimicrobial Resistance

Authors

Collaborators

Affiliations

Comment on

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical